Survival rates lower among African Americans with colon cancer
the ONA take:
African Americans with colon cancer have lower survival rates compared with white patients, despite an overall decline in colon cancer deaths.
However, delivering evidence-based care within an integrated health care system can improve survival rates for this population.
Investigators from the Stanford University School of Medicine evaluated the records of more than 30,000 patients with colon cancer who underwent treatment for their disease, comparing the care delivery with recommendations from the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology for Colon Cancer.
Their study results demonstrated that better overall survival rates were seen in all patients, including minorities, treated with integrated health systems—includes hospital-based care, outpatient services, and rehabilitation.
The investigators conclude that providing evidence-based care that follows the sequential management decisions outlined in the NCCN Guidelines can equalize racial disparities and improve care for all patients.
African Americans with colon cancer have lower survival rates compared with white patients.
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- Breast Conservation Improves Survival vs Mastectomy in Breast Cancer
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|